Abstract
Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased.
| Original language | English |
|---|---|
| Article number | e53 |
| Journal | Antimicrobial Stewardship and Healthcare Epidemiology |
| Volume | 2 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 05-04-2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Epidemiology
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: An experience at a tertiary-care center'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver